Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results Accessibility StatementSkip Navigation Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total cash of $17.3 million as of December 31, 2025 with an additional $10.5 million received subsequent to year end related to divestiture BELGRADE, Mont., March 31, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), ...